FASEB BioAdvances Announces New Editors-in-ChiefMonday, January 10, 2022
FASEB announced today that effective January 1, 2022, FASEB BioAdvances welcomed two new editors-in-chief: Crislyn D’Souza-Schorey, PhD, and Yung Hou Wong, PhD. D’Souza-Schorey is the Morris Pollard Professor of Biological Sciences at the University of Notre Dame where she has served on the faculty since 1998, including a six-year tenure as department chair. Wong is Chair Professor in the Division of Life Science at the Hong Kong University of Science and Technology (HKUST). He also serves as director of the Biotechnology Research Institute and the Molecular Neuroscience Center at HKUST.
“We are thrilled to announce the appointment of two highly-respected, research-active professors, Dr. D’Souza-Schorey and Dr. Wong, to lead our recently launched open access journal FASEB BioAdvances,” said Darla Henderson, PhD, FASEB Director of Publications. “Both have extensive experience serving on journal editorial teams and are committed to a trivium of fair ethical publishing, creating an inclusive environment, and the swift evaluation and open publication of new findings.”
FASEB CEO Frank J. Krause Jr., echoed Henderson’s comments adding, “The appointment of Drs. D’Souza-Schorey and Wong illustrate FASEB’s commitment to excellence and diversity while underscoring the importance of the international community to the success of this journal.”
About Crislyn D’Souza-Schorey, PhD
An accomplished scientist, D’Souza-Schorey’s laboratory has led fundamental studies on how tumor cells invade the surrounding microenvironment. Her research contributions are vast, published in leading scientific journals and well supported by federal, state, as well as foundation sources. Early work from her laboratory laid the groundwork for the role of endocytic trafficking in the disassembly of cadherin-based adhesion and epithelial-to-mesenchymal transitions.
Her laboratory also pioneered the study of a specialized class of extracellular vesicles released from tumor cells by the outward budding and fission of the plasma membrane and showed that these larger tumor microvesicles (TMVs) were distinct from exosomes, promoted cell invasion at distal sites and were formed by the selective sorting of cargo to sites of TMV formation. She has served as associate editor of FASEB BioAdvances since January 2020.
About Yung Hou Wong, PhD
Wong obtained his doctorate in Pharmacology from the University of Cambridge and conducted postdoctoral training at the University of California San Francisco. Since joining HKUST, his research is focused on the delineation of the mechanisms of cell signaling, particularly those involving the G protein-coupled receptors (GPCRs). By utilizing a combination of advanced biochemical, immunological, and molecular biology approaches, he has made significant contributions in elucidating the molecular pharmacology of many GPCRs of therapeutic value, including those for opioid peptides, melatonin, and chemokines.
Wong’s laboratory also demonstrated that numerous GPCRs can regulate gene transcription, cell proliferation and differentiation via complex signaling networks. In addition, he has integrated these functional characteristics into high-throughput drug screening platforms in collaboration with pharmaceutical companies. Wong has served as an associate editor of FASEB BioAdvances since its inception in 2018.